Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.

MLA

Koukourakis, Michael I., et al. “Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 17, no. 14, July 2011, pp. 4892–900. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-10-2918.

APA

Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., Trarbach, T., Folprecht, G., Shi, M. M., Lebwohl, D., Jalava, T., Laurent, D., Meinhardt, G., & Harris, A. L. (2011). Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 17(14), 4892–4900. https://doi.org/10.1158/1078-0432.CCR-10-2918

Chicago

Koukourakis, Michael I, Alexandra Giatromanolaki, Efthimios Sivridis, Kevin C Gatter, Tanja Trarbach, Gunnar Folprecht, Michael M Shi, et al. 2011. “Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 17 (14): 4892–4900. doi:10.1158/1078-0432.CCR-10-2918.